Bradley Rodgers, MD
Obstetrics · Kearney, NENPI 1154405926
Payments from drug & device makers
Across 548 payments — averaging $33.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$5K
- Cue Health Inc.$4K
- AbbVie$2K
- Medtronic$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$769
- Novo Nordisk$554
- plus $5K from 52 others
What the payments were for
- Consulting fees$1,1618%
- Speaking & faculty fees$3,24022%
- Travel & lodging$1,83512%
- Food & beverage$8,74758%
- Education$330%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few obstetrics providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 163 | $102,360 |
| OzempicSemaglutide | 86 | $94,464 |
| JardianceEmpagliflozin | 115 | $92,058 |
| XareltoRivaroxaban | 140 | $69,088 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 87 | $65,100 |
| FarxigaDapagliflozin Propanediol | 66 | $58,425 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $36,470 |
| RybelsusSemaglutide | 31 | $34,799 |
| Xtampza ErOxycodone Myristate | 28 | $27,221 |
| TradjentaLinagliptin | 29 | $21,757 |
| JanuviaSitagliptin Phosphate | 23 | $20,381 |
| MyrbetriqMirabegron | 25 | $17,934 |
| JanumetSitagliptin Phos/Metformin Hcl | 31 | $17,368 |
| MounjaroTirzepatide | 16 | $16,742 |
| LinzessLinaclotide | 16 | $16,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $554 | $129,263117 claims |
| Boehringer IngelheimJardiance, Tradjenta | $40 | $113,815144 claims |
| PfizerEliquis | $346 | $102,360163 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $52 | $95,503151 claims |
| Johnson & JohnsonXarelto | $310 | $69,088140 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $474 | $67,32880 claims |
| MerckJanuvia, Janumet, Janumet Xr | $37 | $43,40165 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $129 | $29,63245 claims |
| AbbVieLinzess, Creon | $2,033 | $23,06136 claims |
| Lilly USA, LLCMounjaro | $364 | $16,74216 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $36 | $7,68415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few obstetrics providers in Nebraskaon file to place this against a meaningful peer group, so we don't.
Other obstetrics in Kearney
- Beth ErnstKearney$4K
- Terry BeckerKearney$3K
- Clinton JonesKearney$38
- Erica HaakeGrand Island$1.8M
- Donald GibbensLincoln$2K
- Dennis HodgeLincoln$498
- Meghen BokemperLincoln$376
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.